Literature DB >> 20209046

IN VITRO TRANSPLANTATION OF GENETICALLY MODIFIED CELLS TO THE TENDON SURFACE.

Paulus J J Couvreur1, Chunfeng Zhao, Stephen Murphy, Peter C Amadio.   

Abstract

The objective of this paper was to study in vitro transfection of tendon cells and adherence of transfected cells to different tendon surfaces. Achilles tendon fibroblasts from 2-month-old New Zealand white rabbits were cultured to confluence, after which the cells were transfected by an adenovirus carrying either the β-galactosidase reporter gene or the green fluorescent protein (GFP) gene at multiplicities of infection (MOIs) of 50, 100, or 500. Two days later, the cells were transplanted onto the surfaces of rabbit Achilles, peroneus brevis, flexor profundus, and extensor longus tendons. The tendons were assessed by X-gal staining after 9 days, and by GFP fluorescence at 7, 14, and 21 days. Twenty percent to 50% of the treated cells stained for β-galactosidase at an MOI of 500. The GFP-labeled cells showed nearly 100% fluorescence at an MOI of 50. No positive cells were visible in the control group. The β-galactosidase and GFP-expressing cells remained viable for as long as 3 weeks. It is possible to introduce foreign genes into rabbit tendon cells, transplant the cells onto tendon surfaces, and maintain viability of the cell/tendon construct for several weeks.

Entities:  

Year:  2008        PMID: 20209046      PMCID: PMC2832611          DOI: 10.1142/S0218957708001961

Source DB:  PubMed          Journal:  J Musculoskelet Res        ISSN: 0218-9577


  24 in total

1.  Cotransfection of heme oxygenase-1 prevents the acute inflammation elicited by a second adenovirus.

Authors:  S D McCarter; J R Scott; P J Lee; X Zhang; A M K Choi; C A McLean; A Badhwar; A A Dungey; A Bihari; K A Harris; R F Potter
Journal:  Gene Ther       Date:  2003-09       Impact factor: 5.250

2.  The Marshall R. Urist Young Investigator Award. Autogenous flexor tendon grafts. Biologic mechanisms for incorporation.

Authors:  J G Seiler; C R Chu; D Amiel; S L Woo; R H Gelberman
Journal:  Clin Orthop Relat Res       Date:  1997-12       Impact factor: 4.176

3.  Surface modification of extrasynovial tendon by chemically modified hyaluronic acid coating.

Authors:  Toshimitsu Momose; Peter C Amadio; Yu-Long Sun; Chunfeng Zhao; Mark E Zobitz; Jeffrey R Harrington; Kai-Nan An
Journal:  J Biomed Mater Res       Date:  2002-02

4.  Adenovirus-mediated gene transfer into tendon and tendon sheath.

Authors:  J Lou; P R Manske; M Aoki; M E Joyce
Journal:  J Orthop Res       Date:  1996-07       Impact factor: 3.494

5.  Gliding resistance of extrasynovial and intrasynovial tendons through the A2 pulley.

Authors:  S Uchiyama; P C Amadio; J H Coert; L J Berglund; K N An
Journal:  J Bone Joint Surg Am       Date:  1997-02       Impact factor: 5.284

6.  Early expression of marker genes in the rabbit medial collateral and anterior cruciate ligaments: the use of different viral vectors and the effects of injury.

Authors:  K A Hildebrand; M Deie; C R Allen; D W Smith; H I Georgescu; C H Evans; P D Robbins; S L Woo
Journal:  J Orthop Res       Date:  1999-01       Impact factor: 3.494

7.  Pulmonary inflammation induced by incomplete or inactivated adenoviral particles.

Authors:  R D McCoy; B L Davidson; B J Roessler; G B Huffnagle; S L Janich; T J Laing; R H Simon
Journal:  Hum Gene Ther       Date:  1995-12       Impact factor: 5.695

8.  Adenoviral-mediated gene transfer to rabbit synovium in vivo.

Authors:  B J Roessler; E D Allen; J M Wilson; J W Hartman; B L Davidson
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.

Authors:  Y Yang; F A Nunes; K Berencsi; E Gönczöl; J F Engelhardt; J M Wilson
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330

10.  Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees.

Authors:  Zhibao Mi; Steven C Ghivizzani; Eric Lechman; Joseph C Glorioso; Christopher H Evans; Paul D Robbins
Journal:  Arthritis Res Ther       Date:  2003-03-12       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.